Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation

被引:23
|
作者
Zhai, Tianyu [1 ,2 ,3 ]
Zhang, Xiaoyu [1 ]
Hei, Zhenyu [1 ]
Jin, Longyang [4 ]
Han, Chao [5 ]
Ko, Audrey Tsznam [6 ]
Yu, Xiaofeng [7 ]
Wang, Jiandong [1 ,2 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Gen Surg, Shanghai, Peoples R China
[2] Shanghai Res Ctr Biliary Tract Dis, Shanghai, Peoples R China
[3] Shanghai Key Lab Biliary Tract Dis Res, Shanghai, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Colorectal Surg, Guangzhou, Peoples R China
[5] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Gen Surg, Shanghai, Peoples R China
[6] Imperial Coll London, Fac Med, London, England
[7] Peoples Hosp Gaoxin Dist, Dept Gen Surg, Suzhou, Peoples R China
关键词
isorhamnetin; gallbladder cancer; tumor progression; PI3K; akt pathway; apoptosis; APOPTOSIS; CARCINOMA; INVASION; PROGRESSION; MODULATION; ACTIVATION;
D O I
10.3389/fphar.2021.628621
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gallbladder cancer (GBC) is the most common biliary tract tumor with a poor prognosis. Isorhamnetin is a flavonoid compound extracted from Hippophae rhamnoides L. and has several pharmacological effects including anti-inflammatory and anti-cancer properties. We treated GBC-SD and NOZ of GBC cell lines with different isorhamnetin concentrations in vitro. A cell counting kit-8 (CCK-8) assay, transwell assay, Hoechst 33342 stain assay, flow cytometric analysis, and a colony-forming assay were performed to investigate the effect of isorhamnetin on the proliferation, apoptosis, metastasis, and cycle arrest of GBC cells. A western blotting assay was conducted to explore the related protein expression level of GBC cells. A mice xenograft model and immunohistochemistry staining were employed to assess the effect of isorhamnetin in vivo. Isorhamnetin was found to suppress cell proliferation and metastasis, and trigger apoptosis and arrest the G2/M phase in GBC cells via the inactivation of the PI3K/AKT signaling cascade. Our findings are of clinical significance in providing a novel treatment approach for GBC.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation (vol 12, 628621, 2021)
    Zhai, Tianyu
    Zhang, Xiaoyu
    Hei, Zhenyu
    Jin, Longyang
    Han, Chao
    Ko, Audrey Tsznam
    Yu, Xiaofeng
    Wang, Jiandong
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [2] Daphnoretin inhibits glioblastoma cell proliferation and metastasis via PI3K/AKT signaling pathway inactivation
    Lei, Jiaming
    Zhou, Hong
    Cheng, Shijiao
    Yu, Wenwen
    Yang, Meiting
    Lin, Li
    [J]. JOURNAL OF CANCER, 2024, 15 (17): : 5810 - 5827
  • [3] Pinocembrin Inhibits the Proliferation and Metastasis of Breast Cancer via Suppression of the PI3K/AKT Signaling Pathway
    Zhu, Xinbing
    Li, Rongnian
    Wang, Chen
    Zhou, Shuo
    Fan, Yujia
    Ma, Shuang
    Gao, Didi
    Gai, Nian
    Yang, Jing
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] Glutinol inhibits the proliferation of human ovarian cancer cells via PI3K/AKT signaling pathway
    Chen, Yuanyuan
    Lie, Juan
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (07) : 1331 - 1335
  • [5] Downregulation of BRD4 inhibits gallbladder cancer proliferation and metastasis and induces apoptosis via PI3K/AKT pathway
    Hao, Jiaqi
    Yang, Ziyi
    Wang, Lei
    Zhang, Yijian
    Shu, Yijun
    Jiang, Lin
    Hu, Yunping
    Lv, Wenjie
    Dong, Ping
    Liu, Yingbin
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 51 (03) : 823 - 831
  • [6] Diosgenin inhibits cell proliferation of primary human thyrocytes via downregulation of PI3K/Akt signaling pathway
    Wen, Fen
    Lu, Yuxian
    Xu, Ke
    Liu, Yanmei
    Qian, Xiaojuan
    Bian, Dezhi
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2018, 17 (07) : 1243 - 1248
  • [7] Matrine inhibits invasion and migration of gallbladder cancer via regulating the PI3K/AKT signaling pathway
    Mo, Rong-Liang
    Li, Zhuang
    Zhang, Peng
    Sheng, Ming-Hui
    Han, Gen-Cheng
    Sun, Deng-Qun
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (10) : 8129 - 8143
  • [8] Wilforol A inhibits human glioma cell proliferation and deactivates the PI3K/AKT signaling pathway
    Wang, Zhihan
    Ren, Li
    Xu, Hao
    Wei, Zilong
    Zeng, Hongjun
    [J]. ACTA BIOCHIMICA POLONICA, 2023, : 123 - 129
  • [9] Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway
    Lin, Lin
    Gao, Yunan
    Hu, Xiaochen
    Ouyang, Jiabao
    Liu, Chunbo
    [J]. BMC WOMENS HEALTH, 2022, 22 (01)
  • [10] Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway
    Lin Lin
    Yunan Gao
    Xiaochen Hu
    Jiabao Ouyang
    Chunbo Liu
    [J]. BMC Women's Health, 22